Prof Moorman speaks with ecancer at EHA 23 about the development and validation of risk of relapse stratification equation for ALL patients.
He explains how, compared to other binary risk factors, continuous data assessment can predict patients at risk of relapse, with the score now validated in a large population and available online.
